These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12854006)

  • 1. Propranolol effects on portal pressure in cirrhotic patients.
    Cavaşi A
    Rom J Gastroenterol; 2003 Jun; 12(2):171-2. PubMed ID: 12854006
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of obzidan on the central and hepatic portal hemodynamics in patients with liver cirrhosis].
    Rusyn VI; Peresta IuIu
    Klin Khir; 1995; (1):7-8. PubMed ID: 9053172
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of propranolol compared with clonidine on portal haemodynamics: a double-blind cross-over study using duplex-Doppler ultrasonography.
    Tincani E; Cioni G; D'Alimonte P; Cristani A; Turrini F; Romagnoli R; Ventura E
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):893-7. PubMed ID: 8574724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
    Piscaglia F; Gaiani S; Siringo S; Gramantieri L; Serra C; Bolondi L
    Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis.
    Schepke M; Raab P; Hoppe A; Schiedermaier P; Brensing KA; Sauerbruch T
    Am J Gastroenterol; 2000 Oct; 95(10):2905-9. PubMed ID: 11051366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis.
    Alvarez D; de las Heras M; Abecasis R; Terg R; Gerona S; Albornoz L; Galdame O; Torres J; Mastai R
    Hepatology; 1997 Mar; 25(3):548-50. PubMed ID: 9049196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ondansetron on portal hemodynamics in liver cirrhosis.
    Tripkovic M; Kozjek F; Krizman I; Jereb J; Francetic I; Grabnar I; Mrhar A
    Int J Clin Pharmacol Ther; 2000 Sep; 38(9):436-40. PubMed ID: 11020031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis].
    Castaño G; Viudez P; Carlevaro O; Ocampo C; Zandalazini H; Riccitelli M; Sookoian S; Frider B
    Acta Gastroenterol Latinoam; 1998; 28(4):291-7. PubMed ID: 10347683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus].
    Santambrogio R; Opocher E; Galeotti F; Montorsi M; Cucchiaro G; Gagliano G; Spina GP
    Minerva Med; 1989 Aug; 80(8):949-51. PubMed ID: 2571957
    [No Abstract]   [Full Text] [Related]  

  • 10. Postprandial vascular response in patients with cirrhosis. Short-term effects of propranolol administration.
    Alvarez D; Miguez C; Podesta A; Terg R; Sanchez Malo A; Bandi JC; Sanchez S; Mastai R
    Dig Dis Sci; 1994 Jun; 39(6):1288-93. PubMed ID: 8200262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
    Ljubicić N; Bilić A
    Scand J Gastroenterol; 1991 Jul; 26(7):751-7. PubMed ID: 1896818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the effect of propranolol on the portal venous pressure and systemic hemodynamics in patients with chronic liver disease].
    Sekiyama T
    Nihon Ika Daigaku Zasshi; 1987 Apr; 54(2):173-83. PubMed ID: 3584407
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
    Wruck U; Wermke W
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of ACE inhibitor (ednit) on portal hemodynamics in patients with hepatic cirrhosis].
    Postnikova TN; Larina EA; Berdnikov SV; Serov NA
    Klin Med (Mosk); 1999; 77(12):46-7. PubMed ID: 10684217
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
    Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
    Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of octreotide on portal hemodynamics in patients with liver cirrhosis].
    Zhu Q; Jiang XH; Yi F; Jiang Y; Sun YW; Yuan YZ; Wu YL
    Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):16-8. PubMed ID: 14990014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of canrenoate potassium, an aldosterone antagonist on portal hemodynamics in patients with compensated liver cirrhosis.
    Koda M; Murawaki Y; Kawasaki H; Ikawa S
    Hepatogastroenterology; 1996; 43(10):887-92. PubMed ID: 8884309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopamine on portal blood flow in cirrhotic patients.
    Kaya N; Yeşildağ O; Kahraman H; Boyunağa H; Demircan C; Yalçintaş U; Kapicioğlu S
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):11-3. PubMed ID: 9512947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.